Sign Up to like & get
recommendations!
1
Published in 2022 at "Science Translational Medicine"
DOI: 10.1126/scitranslmed.abl6328
Abstract: Cyclic adenosine 3′,5′-monophosphate (cAMP)–elevating agents, such as β2-adrenergic receptor (β2-AR) agonists and phosphodiesterase (PDE) inhibitors, remain a mainstay in the treatment of obstructive respiratory diseases, conditions characterized by airway constriction, inflammation, and mucus hypersecretion. However,…
read more here.
Keywords:
camp;
inflammation;
pi3k mimetic;
mimetic peptide ... See more keywords